Earth Science Tech, Inc. Reports Strong Q2 Fiscal 2025 Results
Earth Science Tech (OTC: ETST) reported strong Second Fiscal Quarter results for the period ended September 30, 2025. Key financials: Total Assets $8.66M (+71.64% YoY, +22.65% YTD from $7.07M), Quarterly Revenue $9.05M (+6.24%), Gross Profit $6.72M (+7.3%), and Quarterly Net Profit $0.94M (+18.48%). Outstanding common shares fell to 292.8M, a 3.57% reduction YoY. Management described the quarter as execution of its strategy to acquire and scale high-potential operating businesses and cited asset growth and share reduction as evidence of shareholder-value focus.
Earth Science Tech (OTC: ETST) ha riportato solidi risultati per il secondo trimestre fiscale per il periodo terminato 30 settembre 2025. Principali dati finanziari: Attivi totali $8.66M (+71.64% YoY, +22.65% YTD da $7.07M), Ricavi trimestrali $9.05M (+6.24%), Utile lordo $6.72M (+7.3%), e Utile netto trimestrale $0.94M (+18.48%). Le azioni ordinarie in circolazione sono diminuite a 292.8M, una riduzione del 3.57% YoY. La direzione ha descritto il trimestre come esecuzione della strategia di acquisire e scalare aziende operative ad alto potenziale e ha citato la crescita degli asset e la riduzione delle azioni come evidenza di un focus sul valore per gli azionisti.
Earth Science Tech (OTC: ETST) informó resultados sólidos del segundo trimestre fiscal para el periodo terminado el 30 de septiembre de 2025. Principales métricas financieras: Activos totales $8.66M (+71.64% interanual, +22.65% YTD desde $7.07M), Ingresos trimestrales $9.05M (+6.24%), Utilidad bruta $6.72M (+7.3%), y Utilidad neta trimestral $0.94M (+18.48%). Las acciones comunes en circulación cayeron a 292.8M, una reducción del 3.57% interanual. La dirección describió el trimestre como la ejecución de su estrategia para adquirir y escalar negocios operativos de alto potencial y citó el crecimiento de activos y la reducción de acciones como evidencia del enfoque en el valor para los accionistas.
Earth Science Tech (OTC: ETST)는 2025년 9월 30일에 종료된 기간의 2분기 실적이 강하게 발표되었습니다. 주요 재무 수치는 총자산 $8.66M (전년 대비 +71.64%, 연초 이후 +22.65% from $7.07M), 분기 매출 $9.05M (+6.24%), 총이익 $6.72M (+7.3%), 및 분기 순이익 $0.94M (+18.48%). 발행주식 수는 292.8M으로 전년 대비 3.57% 감소했습니다. 경영진은 이 분기를 고성능 운영 비즈니스를 인수하고 확장하려는 전략의 실행으로 설명했고 자산 증가와 주가 감소를 주주 가치에 대한 집중의 증거로 제시했습니다.
Earth Science Tech (OTC: ETST) a annoncé des résultats solides du deuxième trimestre fiscal pour la période se terminant le 30 septembre 2025. Principaux indicateurs financiers : Actifs totaux 8,66 M$ (+71,64% en glissement annuel, +22,65% à ce jour par rapport à 7,07 M$), Chiffre d'affaires trimestriel 9,05 M$ (+6,24%), Bénéfice brut 6,72 M$ (+7,3%), et Bénéfice net trimestriel 0,94 M$ (+18,48%). Le nombre d'actions ordinaires en circulation a diminué à 292,8 M, soit une baisse de 3,57% en glissement annuel. La direction a décrit le trimestre comme l'exécution de sa stratégie consistant à acquérir et à faire croître des entreprises opérationnelles à fort potentiel et a cité la croissance des actifs et la réduction du nombre d'actions comme preuves de l'accent mis sur la valeur pour les actionnaires.
Earth Science Tech (OTC: ETST) meldete starke Ergebnisse des zweiten Geschäftsjahresquartals für den Zeitraum zum 30. September 2025. Wichtige Finanzkennzahlen: Gesamtvermögen $8.66M (+71.64% YoY, +22.65% YTD gegenüber $7.07M), Quartalsumsatz $9.05M (+6.24%), Bruttogewinn $6.72M (+7.3%), und Quartal Nettogewinn $0.94M (+18.48%). Ausstehende Stammaktien gingen auf 292.8M zurück, eine Reduktion um 3.57% YoY. Das Management beschrieb das Quartal als Umsetzung der Strategie, hochpotenzielle operative Unternehmen zu erwerben und zu skalieren, und nannte Vermögenswachstum und Aktieneinschränkungen als Belege für den Fokus auf den Aktionärswert.
Earth Science Tech (OTC: ETST) أبلغت عن نتائج قوية للربع الثاني من السنة المالية للفترة المنتهية في 30 سبتمبر 2025. المؤشرات المالية الرئيسية: إجمالي الأصول 8.66 مليون دولار (+71.64% على أساس سنوي، +22.65% حتى تاريخه من 7.07 مليون دولار)، إيرادات ربع سنوية 9.05 مليون دولار (+6.24%), ربح إجمالي 6.72 مليون دولار (+7.3%), وصافي الربح للربع 0.94 مليون دولار (+18.48%). انخفضت عدد الأسهم العادية القائمة إلى 292.8 مليون، بانخفاض قدره 3.57% على أساس سنوي. وصفت الإدارة الربع بأنه تنفيذ لاستراتيجيتها في الاستحواذ وتوسيع أعمال تشغيلية ذات إمكانات عالية، وأشارت إلى نمو الأصول وتقليل عدد الأسهم كدليل على التركيز على قيمة المساهمين.
- Total assets increased 71.64% YoY to $8.66M
- Assets up 22.65% YTD since March 31, 2025
- Quarterly net profit rose 18.48% to $0.94M
- Gross profit increased 7.3% to $6.72M
- None.
MIAMI, FL, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential operating businesses, today announced its financial and operational results for the Second Fiscal Quarter ended September 30, 2025.
Key Shareholder Highlights
- Total Assets Increased
71.64% (YOY): Total Assets increased significantly to$8.66 million (up from$5.04 million in Q2 2024). - Total Assets Up
22.65% (YTD): Total Assets grew from$7.07 million at the March 31, 2025, Year-End to$8.66 million . - Share Count Reduced
3.57% (YOY): Outstanding common shares reduced to 292.8 million shares, demonstrating a commitment to enhancing shareholder value. - Quarterly Net Profit Increased
18.48% : Net Profit (3-month) rose to$0.94 million . - Quarterly Revenue Up
6.24% : Quarterly Revenue (3-month) grew to$9.05 million . - Gross Profit Up
7.3% : Gross Profit (3-month) increased to$6.72 million .
ETST’s CEO & Chairman of the Board comments, “Our second quarter demonstrates successful execution of our strategy to scale high-potential businesses. The
About Earth Science Tech, Inc.
Earth Science Tech, Inc. operates as a strategic holding company, focused on value creation through the acquisition, operational optimization, and management of its operating businesses. The Company’s current operations include compounding pharmaceuticals, telemedicine and real estate development through its wholly owned subsidiaries: RxCompoundStore.com, LLC, Peaks Curative, LLC, Avenvi, LLC, Mister Meds, LLC (“Mister Meds”), and Earth Science Foundation, Inc., Las Villas Health Care, Inc., DOConsultations, LLC., and an
To learn more, please visit: www.EarthScienceTech.com
RxCompoundStore.com, LLC.
RxCompoundStore.Com, based in Miami, Florida, is a fully licensed compounding pharmacy authorized to fulfill prescriptions in the following states and territories: Arizona, Colorado, Delaware, Florida, Georgia, Illinois, Indiana, Iowa, Maine, Maryland, Minnesota, Missouri, Nevada, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Rhode Island, Utah, Wisconsin and Puerto Rico. RxCompound is actively pursuing licensure in the remaining U.S. states.
To learn more please visit: www.RxCompoundStore.com
MisterMeds, LLC.
Mister Meds, acquired on October 1, 2024, is in Abilene, Texas. The pharmacy received full compounding licensure in March 2025. It operates out of a 5,000 sq. ft. facility owned by Avenvi and includes advanced sterile compounding capabilities with both positive and negative pressure environments, as well as hazardous drug handling. Mister Meds is currently applying for licensure in states not yet serviced by RxCompound.
To learn more please visit: www.mistermeds.com
Peaks Curative, LLC.
Peaks is a telemedicine referral platform offering asynchronous consultations for Peaks-branded compounded medications prepared at RxCompound and Mister Meds. The platform operates in states where either pharmacy is licensed. Through the development of its own healthcare provider network, MyOnlineConsultation.com, and ongoing licensure expansion for both pharmacies, Peaks aims to offer services nationwide. In addition, the company has recently expanded into the veterinary market through the acquisition of Zoolzy.com.
To learn more please visit: www.PeaksCurative.com
Las Villas Health Care, Inc.
Las Villas is a brick-and-mortar healthcare facility dedicated to the Spanish speaking community. Our expert-led services include advanced sexual health treatments, and customized solutions to enhance physical performance. We combine compassionate, personalized care with clear, trustworthy education—empowering you to take control of your health with confidence.
To learn more please visit: https://villashealth.com
Doconsultation.com, LLC.
Doconsultation was born with a passion to modernize the availability and delivery of home therapies. DOConsultations providers tailor a medication plan around your health and wellness goals and follow up with our patients to ensure results, while our partner pharmacies conveniently ship directly to your door.
To learn more please visit: https://doconsultations.com/
Avenvi, LLC.
Avenvi is a diversified real estate company engaged in development, asset management, and financing. With a growing portfolio of real estate holdings, Avenvi provides turnkey solutions from development to end-user financing. It also manages investment activities for ETST and oversees the Company’s ongoing
To learn more please visit: www.avenvi.com
MagneChef
MagneChef is a direct-to-consumer retail brand. Utilizing its patents and intellectual properties, the company aims to develop new products that can be marketed and sold online. Currently, the company has developed products for cooking. MagneChef is in the process of expanding its product line for new offerings that incorporate its intellectual property. In addition, the company has recently expanded into the premium American-made BBQ tool brand market through the acquisition of BBQraft.
To learn more please visit: https://magnechef.com/
About Earth Science Foundation, Inc.
Earth Science Foundation Inc. a 501(c)(3) nonprofit organization incorporated on February 11, 2019, is the charitable arm of ETST. ESF accepts grants and donations to assist individuals who need financial support for prescription costs at both RxCompound and Mister Meds.
SAFE HARBOR ACT: Forward-Looking Statements. Except for historical information, the matters discussed herein may be considered “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended.
Such statements include declarations regarding the intent, belief or current expectations of the Company and its management, including, without limitation, future-oriented statements related to cash flow, gross margins, revenues, and expenses. These statements are based on and reflect our current expectations, estimates, assumptions and/or projections, our perception of historical trends and current conditions, as well as other factors that we believe are appropriate and reasonable under the circumstances. Forward-looking statements generally can be identified by the fact that they do not relate strictly to historical or current facts. They may include forward-looking words such as “expect,” “expectation,” “believe,” “anticipate,” “may,” “could,” “intend,” “belief,” “plan,” “estimate,” “target,” “predict,” “likely,” “seek,” “project,” “model,” “ongoing,” “will,” “should,” “forecast,” “outlook” or similar terminology. Forward-looking statements are subject to a number of risks and uncertainties that may cause the Company’s actual results to differ materially from our intent, belief or current expectations, including, inter alia, the markets for the Company’s products and services, costs of goods and services, other expenses, government regulations, litigations, and general business conditions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. The Company assumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.
Company Contact:
Giorgio R. Saumat
CEO and Chairman of the Board
(305) 724-5684
IR@earthsciencetech.com